Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29537569 | 1.00 | KDM4E (0.74) | KDM4EPOLBKMT2APDE4BTSHR | |
| SCHEMBL8484361 | 0.94 | KDM4E (0.66) | KDM4EPOLBKMT2APDE4BTSHR | |
| SCHEMBL22229873 | 0.92 | KDM4E (0.62) | KDM4EPOLBKMT2APDE4BTSHR | |
| SCHEMBL31737057 | 0.88 | KDM4E (0.74) | KDM4EPDE4BTSHRMAPK1SMN1; SMN2 | |
| SCHEMBL14907128 | 0.88 | KDM4E (0.74) | KDM4EPDE4BTSHRMAPK1SMN1; SMN2 | |
| SCHEMBL3547607 | 0.87 | KDM4E (0.72) | KDM4EPOLBKMT2APDE4BTSHR | |
| SCHEMBL1067955 | 0.87 | KDM4E (0.72) | KDM4EPOLBKMT2APDE4BTSHR | |
| SCHEMBL31737297 | 0.85 | KDM4E (0.71) | KDM4EPOLBKMT2APDE4BTSHR | |
| SCHEMBL680755 | 0.85 | KDM4E (0.71) | KDM4EPOLBKMT2APDE4BTSHR | |
| SCHEMBL28326914 | 0.85 | KDM4E (1.00) | KDM4EPOLBKMT2APDE4BTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11953833-B2 | Compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and transistor production method | NIKON CORPORATION (JP) | 2024-04-09 | — | — | US | disclosed |
| US-11225461-B2 | Compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and transistor production method | NIKON CORPORATION (JP) | 2022-01-18 | — | — | US | disclosed |
| US-11225461-B2 | Compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and transistor production method | NIKON CORPORATION (JP) | 2022-01-18 | — | — | US | disclosed |
| US-20200233304-A1 | COMPOUND, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD, AND TRANSISTOR PRODUCTION METHOD | NIKON CORPORATION (JP) | 2020-07-23 | — | — | US | disclosed |
| US-20190352260-A1 | COMPOUND, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD, AND TRANSISTOR PRODUCTION METHOD | NIKON CORPORATION (JP) | 2019-11-21 | — | — | US | disclosed |
| US-20190352260-A1 | COMPOUND, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD, AND TRANSISTOR PRODUCTION METHOD | NIKON CORPORATION (JP) | 2019-11-21 | — | — | US | disclosed |
| US-5372949-A | Medical diagnosis | ABBOTT LABORATORIES (US) | 1994-12-13 | — | — | US | disclosed |
| US-5371296-A | Light stability, sunburn prevention | KAO CORPORATION (JP) | 1994-12-06 | — | — | US | disclosed |
| US-5191121-A | Sunscreen | KAO CORPORATION (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0504844-A2 | 4,4-Dimethyl-1-phenylpentane-1,3-dione derivative and UV ray absorbent and cosmetic containing the same | KAO CORPORATION (JP) | 1992-09-23 | — | — | EP | disclosed |
| US-5145791-A | Immunology | ABBOTT LABORATORIES (US) | 1992-09-08 | — | — | US | disclosed |
| EP-0252405-A2 | 3-methoxy-4-hydroxyphenylglycol fluorescence polarization immunoassay | ABBOTT LABORATORIES (US) | 1988-01-13 | — | — | EP | disclosed |
| US-4707481-A | Pyridazinones, their preparation and use, and bronchospasmolytic medicaments containing pyridazinones | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1987-11-17 | — | — | US | disclosed |
| EP-0125636-B1 | PYRIDAZINONES, THEIR PREPARATION AND USE, MEDICINES CONTAINING THESE PYRIDAZINONES | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1987-04-01 | — | — | EP | disclosed |
| WO-1984004521-A1 | PYRIDAZINONES, THEIR PREPARATION AND USE, AND MEDICAMENTS CONTAINING PYRIDAZINONES | BYK GULDEN LOMBERG CHEM FAB (DE) | 1984-11-22 | — | — | WO | disclosed |
| EP-0125636-A1 | Pyridazinones, their preparation and use, medicines containing these pyridazinones | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11953833-B2 | Compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and transistor production method | CYP1A1, CYP1A2, CYP1B1 | KDM4E 4675/4885POLB 1448/4885KMT2A 3481/4885 |
| US-20200233304-A1 | COMPOUND, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD, AND TRANSISTOR PRODUCTION METHOD | CYP1A1, CYP1A2, CYP1B1 | KDM4E 4675/4885POLB 1448/4885KMT2A 3481/4885 |
| US-11225461-B2 | Compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and transistor production method | CYP3A4, CYP4F11, COASY | KDM4E 4699/4885POLB 1659/4885KMT2A 3102/4885 |
| US-20190352260-A1 | COMPOUND, SUBSTRATE FOR PATTERN FORMATION, PHOTODEGRADABLE COUPLING AGENT, PATTERN FORMATION METHOD, AND TRANSISTOR PRODUCTION METHOD | CYP3A4, CYP4F11, COASY | KDM4E 4699/4885POLB 1659/4885KMT2A 3102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.